Monday, 11 May 2015 10:09

Measuring Circulating Tumor DNA for Recurrence in DLBCL

Written by 
Rate this item
(1 Vote)
Written interview with Dr. Mark Roschewski MD and Dr Wyndham H Wilson MD-PhD from National Cancer Institute. They nvestigated the ability of a blood-based assay to monitor patients with DLBCL during and after their initial therapy. The assay studied amplifies and quantifies small amounts of circulating tumor DNA from the patient
Read 282835 times

 

Global Database Search

 knowyoursubtype iconb   facebook2 twitter2 youtube1

IN THE NODE

Updates

 knowyoursubtype iconb   facebook2 twitter2 youtube1 Contact Us 

The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.